BCAR shareholders approve business combination with Exascale Labs; ~96% of public shares redeemed

D. Boral ARC Acquisition I Corp.

Shareholders approved the Business Combination Agreement and all related proposals at the July 29, 2026 extraordinary general meeting.
26,865,211 Class A ordinary shares (95.95% of outstanding public shares) were elected for redemption.
Approximately $12 million remains in BCAR's trust account after redemptions, meeting the minimum cash closing condition.
Combined company to be named Exascale Labs Holdings Inc., trading under tickers XLAB and XLABW on Nasdaq.
No additional financing is currently anticipated prior to closing; closing expected shortly.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.